×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Global Longlife Hospital and R | NA | NA | NA | NA | 24.2 | 121.0 |
| ISHITA DRUGS & INDUSTRIES LTD. | NA | NA | NA | NA | 22 | 21.5 |
| PHAARMASIA LTD. | NA | NA | NA | NA | 21.9 |
Global Longlife Hospital and Research Limited, with Security Code 543520, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|---|
| Sales | 12.9 | 11.8 | 11.7 | 12.3 |
| Expenses | 11.6 | 10.0 | 9.4 | 9.6 |
| Operating Profit | 1.3 | 1.8 | 2.3 | 2.7 |
| OPM % | 9.77% | 15.06% | 19.3% | 21.97% |
| Other Income | 0.2 | 0.1 | 0.2 | 0.0 |
| Interest | 1.3 | 0.2 | 0.2 | 0.4 |
| Depreciation | 0.6 | 0.6 | 0.6 | 0.6 |
| Profit before tax | -0.5 | 1.1 | 1.6 | 1.7 |
| Tax % | 468.4% | -28.8% | -35% | -39.8% |
| Net Profit | -2.6 | 0.8 | 1.1 | 1.0 |
| EPS in Rs | -3.7 | 0.72 | 1.05 | 0.98 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -56% |
| 3 Years: | -74% |
| TTM: | -96% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | -62% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -27% |
| 1 Year: | -5% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|